Cargando…
Evidence That Selenium Binding Protein 1 Is a Tumor Suppressor in Prostate Cancer
Selenium-Binding Protein 1 (SBP1, SELENBP1, hSP56) is a selenium-associated protein shown to be at lower levels in tumors, and its lower levels are frequently predictive of a poor clinical outcome. Distinguishing indolent from aggressive prostate cancer is a major challenge in disease management. As...
Autores principales: | Ansong, Emmanuel, Ying, Qi, Ekoue, Dede N., Deaton, Ryan, Hall, Andrew R., Kajdacsy-Balla, Andre, Yang, Wancai, Gann, Peter H., Diamond, Alan M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4436248/ https://www.ncbi.nlm.nih.gov/pubmed/25993660 http://dx.doi.org/10.1371/journal.pone.0127295 |
Ejemplares similares
-
Correlations of SELENOF and SELENOP genotypes with serum selenium levels and prostate cancer
por: Ekoue, Dede N., et al.
Publicado: (2018) -
GPX1 Localizes to the Nucleus in Prostate Epithelium and its Levels are not Associated with Prostate Cancer Recurrence
por: Ekoue, Dede N., et al.
Publicado: (2018) -
A Critical Role for Cysteine 57 in the Biological Functions of Selenium Binding Protein-1
por: Ying, Qi, et al.
Publicado: (2015) -
Selenium-binding protein 1 as a tumor suppressor and a prognostic indicator of clinical outcome
por: Yang, Wancai, et al.
Publicado: (2013) -
Quantitative Proteomic Analysis Reveals That Anti-Cancer Effects of Selenium-Binding Protein 1 In Vivo Are Associated with Metabolic Pathways
por: Ying, Qi, et al.
Publicado: (2015)